Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
74.1M
-
Number of holders
-
171
-
Total 13F shares, excl. options
-
66.5M
-
Shares change
-
+16.9K
-
Total reported value, excl. options
-
$973M
-
Value change
-
+$2.71M
-
Put/Call ratio
-
0.58
-
Number of buys
-
69
-
Number of sells
-
-81
-
Price
-
$14.64
Significant Holders of Zymeworks Inc. - Common Stock, par value $0.00001 per share (ZYME) as of Q4 2024
195 filings reported holding ZYME - Zymeworks Inc. - Common Stock, par value $0.00001 per share as of Q4 2024.
Zymeworks Inc. - Common Stock, par value $0.00001 per share (ZYME) has 171 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 66.5M shares
of 74.1M outstanding shares and own 89.7% of the company stock.
Largest 10 shareholders include EcoR1 Capital, LLC (15M shares), Redmile Group, LLC (4.84M shares), BVF INC/IL (4.31M shares), MORGAN STANLEY (4.2M shares), BlackRock, Inc. (4.18M shares), Rubric Capital Management LP (3.92M shares), VANGUARD GROUP INC (2.49M shares), BNP PARIBAS ASSET MANAGEMENT Holding S.A. (2.14M shares), PERCEPTIVE ADVISORS LLC (2.13M shares), and DEUTSCHE BANK AG\ (1.55M shares).
This table shows the top 171 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.